The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Migraine Medicine Market Research Report 2024
Synopsis
Over-the-counter (OTC) migraine medicines are non-prescription medications that can be purchased directly from a pharmacy or retail store without a doctor's prescription. These medicines are intended to provide relief from the symptoms of migraines, such as headache, nausea, and sensitivity to light and sound.
Global OTC Migraine Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Migraine Medicine market research.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Migraine Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
GSK
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Segment by Type
NSAIDs
Acetaminophen
Others
Segment by Application
Drug Stores
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Migraine Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Over-the-counter (OTC) migraine medicines are non-prescription medications that can be purchased directly from a pharmacy or retail store without a doctor's prescription. These medicines are intended to provide relief from the symptoms of migraines, such as headache, nausea, and sensitivity to light and sound.
Global OTC Migraine Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Migraine Medicine market research.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Migraine Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
GSK
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Segment by Type
NSAIDs
Acetaminophen
Others
Segment by Application
Drug Stores
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Migraine Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Migraine Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Others
1.3 Market by Application
1.3.1 Global OTC Migraine Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Stores
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Migraine Medicine Market Perspective (2018-2029)
2.2 OTC Migraine Medicine Growth Trends by Region
2.2.1 Global OTC Migraine Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Migraine Medicine Historic Market Size by Region (2018-2023)
2.2.3 OTC Migraine Medicine Forecasted Market Size by Region (2024-2029)
2.3 OTC Migraine Medicine Market Dynamics
2.3.1 OTC Migraine Medicine Industry Trends
2.3.2 OTC Migraine Medicine Market Drivers
2.3.3 OTC Migraine Medicine Market Challenges
2.3.4 OTC Migraine Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Migraine Medicine Players by Revenue
3.1.1 Global Top OTC Migraine Medicine Players by Revenue (2018-2023)
3.1.2 Global OTC Migraine Medicine Revenue Market Share by Players (2018-2023)
3.2 Global OTC Migraine Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Migraine Medicine Revenue
3.4 Global OTC Migraine Medicine Market Concentration Ratio
3.4.1 Global OTC Migraine Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Migraine Medicine Revenue in 2022
3.5 OTC Migraine Medicine Key Players Head office and Area Served
3.6 Key Players OTC Migraine Medicine Product Solution and Service
3.7 Date of Enter into OTC Migraine Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Migraine Medicine Breakdown Data by Type
4.1 Global OTC Migraine Medicine Historic Market Size by Type (2018-2023)
4.2 Global OTC Migraine Medicine Forecasted Market Size by Type (2024-2029)
5 OTC Migraine Medicine Breakdown Data by Application
5.1 Global OTC Migraine Medicine Historic Market Size by Application (2018-2023)
5.2 Global OTC Migraine Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Migraine Medicine Market Size (2018-2029)
6.2 North America OTC Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Migraine Medicine Market Size by Country (2018-2023)
6.4 North America OTC Migraine Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Migraine Medicine Market Size (2018-2029)
7.2 Europe OTC Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Migraine Medicine Market Size by Country (2018-2023)
7.4 Europe OTC Migraine Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Migraine Medicine Market Size (2018-2029)
8.2 Asia-Pacific OTC Migraine Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Migraine Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Migraine Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Migraine Medicine Market Size (2018-2029)
9.2 Latin America OTC Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Migraine Medicine Market Size by Country (2018-2023)
9.4 Latin America OTC Migraine Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Migraine Medicine Market Size (2018-2029)
10.2 Middle East & Africa OTC Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Migraine Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Migraine Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson OTC Migraine Medicine Introduction
11.1.4 Johnson & Johnson Revenue in OTC Migraine Medicine Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK OTC Migraine Medicine Introduction
11.2.4 GSK Revenue in OTC Migraine Medicine Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer OTC Migraine Medicine Introduction
11.3.4 Bayer Revenue in OTC Migraine Medicine Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Haleon
11.4.1 Haleon Company Detail
11.4.2 Haleon Business Overview
11.4.3 Haleon OTC Migraine Medicine Introduction
11.4.4 Haleon Revenue in OTC Migraine Medicine Business (2018-2023)
11.4.5 Haleon Recent Development
11.5 Tongde Pharmacy
11.5.1 Tongde Pharmacy Company Detail
11.5.2 Tongde Pharmacy Business Overview
11.5.3 Tongde Pharmacy OTC Migraine Medicine Introduction
11.5.4 Tongde Pharmacy Revenue in OTC Migraine Medicine Business (2018-2023)
11.5.5 Tongde Pharmacy Recent Development
11.6 Huazhong Pharmaceutical
11.6.1 Huazhong Pharmaceutical Company Detail
11.6.2 Huazhong Pharmaceutical Business Overview
11.6.3 Huazhong Pharmaceutical OTC Migraine Medicine Introduction
11.6.4 Huazhong Pharmaceutical Revenue in OTC Migraine Medicine Business (2018-2023)
11.6.5 Huazhong Pharmaceutical Recent Development
11.7 Weisen Pharmaceutical
11.7.1 Weisen Pharmaceutical Company Detail
11.7.2 Weisen Pharmaceutical Business Overview
11.7.3 Weisen Pharmaceutical OTC Migraine Medicine Introduction
11.7.4 Weisen Pharmaceutical Revenue in OTC Migraine Medicine Business (2018-2023)
11.7.5 Weisen Pharmaceutical Recent Development
11.8 DIAO GROUP
11.8.1 DIAO GROUP Company Detail
11.8.2 DIAO GROUP Business Overview
11.8.3 DIAO GROUP OTC Migraine Medicine Introduction
11.8.4 DIAO GROUP Revenue in OTC Migraine Medicine Business (2018-2023)
11.8.5 DIAO GROUP Recent Development
11.9 Jiheng Pharmaceutical
11.9.1 Jiheng Pharmaceutical Company Detail
11.9.2 Jiheng Pharmaceutical Business Overview
11.9.3 Jiheng Pharmaceutical OTC Migraine Medicine Introduction
11.9.4 Jiheng Pharmaceutical Revenue in OTC Migraine Medicine Business (2018-2023)
11.9.5 Jiheng Pharmaceutical Recent Development
11.10 Dirui Pharmaceutical
11.10.1 Dirui Pharmaceutical Company Detail
11.10.2 Dirui Pharmaceutical Business Overview
11.10.3 Dirui Pharmaceutical OTC Migraine Medicine Introduction
11.10.4 Dirui Pharmaceutical Revenue in OTC Migraine Medicine Business (2018-2023)
11.10.5 Dirui Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
